GUJARAT THEMIS BIOSYN LTD Share Price

GUJARAT THEMIS BIOSYN LTD Share Price

NSE: GUJTHEM
|
Pharmaceuticals
|
S Cap
₹ 428.25
+₹15.20 (3.68%)
1D
Last updated 03 Sep, 2026, 14:00 IST

GUJARAT THEMIS BIOSYN LTD Share Price Today

As of 3 Sep 2026, GUJARAT THEMIS BIOSYN LTD share price is ₹428.25. The stock opened at ₹420.00, compared to its previous close of ₹413.05. During today's trading session, GUJARAT THEMIS BIOSYN LTD share price moved in the range of ₹412.85 to ₹435.00, with an average price of ₹423.93 for the day. Looking at its last 52-week, the stock has touched a low of ₹225.05 and a high of ₹479.00. On the performance front, GUJARAT THEMIS BIOSYN LTD share price has increased by 39.50% over the last six months and is up 9.49% on a year-on-year basis.

₹412.85
3.68% up today
₹435.00
1D LOW
1D HIGH

GUJARAT THEMIS BIOSYN LTD Returns Calculator

Circuit
L
H
₹330.45
₹495.65
52-week
L
H
₹225.05
₹479.00

About GUJARAT THEMIS BIOSYN LTD

GUJARAT THEMIS BIOSYN LTD Share Price
ISIN
INE942C01045
Sector Market Cap
₹ 5,370.06 Cr

Gujarat Themis Biosyn Limited is an India-based company, which is principally engaged in the manufacturing of pharmaceuticals and medicinal chemical products. The Company is focused on the business of manufacturing and sale of finished active pharmaceutical ingredients (API) products by fermentation process. The Company operates through pharmaceuticals segment. Its product portfolio comprises Rifamycin-S and Lovastatin. The Company is manufacturing Rifamycin S, which is an intermediate for manufacturing the drug Rifampicin (an Antibiotic used for the treatment of several types of bacterial infections, including tuberculosis, Mycobacterium avium complex, leprosy, and Legionnaires' disease.) and Rifamycin O, which is an intermediate for manufacturing the drug Rifaximin (this is an Antibiotic used for treatment of traveler's diarrhea, irritable bowel syndrome, and hepatic encephalopathy).

GUJARAT THEMIS BIOSYN LTD Financial Highlights

  • Revenue: GUJARAT THEMIS BIOSYN LTD reported revenue of ₹168.25 crore in FY26 vs ₹153.23 crore in FY25. It showed an increase of 9.80% on a yearly basis.
  • Operating Profit: GUJARAT THEMIS BIOSYN LTD reported an operating profit of ₹62.09 crore in FY26 vs ₹65.54 crore in FY25. It showed a decrease of 5.26% on a year-on-year basis.
  • Net Profit: GUJARAT THEMIS BIOSYN LTD reported a net profit of ₹46.68 crore in FY26 vs ₹48.77 crore in FY25. It showed a decrease of 4.29% on a yearly basis.

GUJARAT THEMIS BIOSYN LTD Quarterly Result Highlights

  • GUJARAT THEMIS BIOSYN LTD reported revenue of ₹43.92 crore in Jun 2026, compared with ₹45.15 crore in Mar 2026, representing a decrease of 2.72% on a quarter-on-quarter (QoQ) basis.
  • GUJARAT THEMIS BIOSYN LTD reported an operating profit of ₹15.17 crore in Jun 2026, compared with ₹14.34 crore in Mar 2026, representing an increase of 5.79% on a quarter-on-quarter (QoQ) basis.
  • GUJARAT THEMIS BIOSYN LTD reported a profit of ₹11.07 crore in Jun 2026, compared with ₹10.89 crore in Mar 2026, reflecting an increase of 1.65% on a QoQ basis.
Know more
Promoters
70.86%
FII
1.77%
Other DII
0.01%
Retail and other
26.19%
Mutual funds
1.16%
Foreign institutions - FII
FII shareholding by period
Sep 20252.95%
Dec 20251.96%
Mar 20261.80%
Jun 20261.77%
Mkt Cap Cr
5,370.06
P/E
110.32
P/B
5.17
ROE
16.22%
D/E
0.56
ROCE
14.47%
Div. Yield
0.14%
EPS(TTM)
4.28
Turnover
0.35
EV/EBITDA
55.87
Net Margin
0.00%
Op. Margin
0.00%
ROA
9.67%
Quick Ratio
0.00
Curr. Ratio
1.93
Based on fundamentals, this stock's
Step 5 of 5
Performance
Excellent
Guj. Themis Bio. outperforming all market indices
Step 1 of 5
Valuation
Overvalued
Guj. Themis Bio. appears overvalued compared to its peers
Step 3 of 5
Earnings
Neutral
Guj. Themis Bio. earnings growth is positive
Peer Comparison
Peer comparison — key ratios
NameMkt Cap CrP/EP/BROED/EROCEBook ValueDiv. YieldTurnoverEPS(TTM)
Sun Pharmaceutical Industries4,63,791.0038.285.5513.74%0.6117.33%93.240.83%0.4810.90
Divis Laboratories2,45,081.0083.7914.6215.32%0.0019.56%629.490.32%0.5598.19
Torrent Pharmaceuticals1,90,351.0088.2922.6425.49%1.6913.85%222.760.68%0.4958.70
Zydus Lifesciences1,14,833.0025.004.2418.59%0.3117.35%237.300.09%0.3335.38
Cipla1,14,163.0034.023.3211.27%0.0014.95%423.360.92%0.4543.52
Laurus Labs1,00,660.0092.3218.9916.77%0.4016.14%97.200.11%0.6713.72
Lupin98,431.0017.734.3823.76%0.0424.88%659.000.84%0.57129.18
Dr. Reddy's Laboratories96,906.3030.442.5511.07%0.1812.54%377.950.69%0.4138.68
Mankind Pharma97,467.0047.546.0311.74%0.3413.13%396.980.04%0.4449.37
Aurobindo Pharma95,299.8025.682.529.25%0.1911.76%394.820.24%0.3841.58

GUJARAT THEMIS BIOSYN LTD Financials

Full statement

Income Statement · Consolidated

Income Statement · Consolidated — all values in INR Crore
ParticularsMar 2026
Revenue168.25
Operating profit62.09
Net profit46.68

Income Statement · Standalone

Income Statement · Standalone — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Revenue₹150.80₹169.82₹148.39₹114.85
Other Income₹1.67₹4.37₹6.59₹4.05
Total Revenue₹152.47₹174.19₹154.97₹118.90
Total Expenses₹86.94₹94.85₹77.51₹59.87
Profit Before Tax₹65.54₹79.33₹77.46₹59.03
Tax₹16.77₹20.17₹19.50₹15.41
Profit After Tax₹48.77₹59.16₹57.97₹43.62
EPS - Basic₹4.48₹40.72₹39.90₹30.03
EPS - Diluted₹4.48₹40.72₹39.90₹30.03

Cash Flow · Standalone

Cash Flow · Standalone — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Profit before tax₹65.54₹79.33₹77.46₹59.03
Income before WC changes₹70.63₹79.80₹75.01₹59.19
Change in Assets₹31.45₹3.82-₹15.64-₹9.10
Change in Liabilities₹5.43₹0.38₹0.53₹4.74
Change in WC₹36.88₹4.19-₹15.11-₹4.36
Cash flow from Operations₹91.03₹64.21₹39.48₹40.31
Cash flow from Investing-₹111.82-₹55.21-₹20.41-₹29.83
Cash flow from Financing₹26.01-₹8.59-₹13.27-₹14.00
Total Cash Flow₹5.22₹0.41₹5.79-₹3.51
Cash (Start of the year)₹6.47₹6.06₹0.26₹3.97
Cash (End of the year)₹11.69₹6.47₹6.06₹0.46

Balance Sheet · Standalone

Balance Sheet · Standalone — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Non-Current Assets₹249.34₹173.55₹104.60₹44.11
Current Assets₹51.97₹47.56₹61.73₹78.39
Total Assets₹301.31₹221.11₹166.33₹122.50
Current Liabilities₹20.56₹16.16₹15.28₹17.16
Net Current Asset₹31.41₹31.40₹46.45₹61.23
Non-Current Liabilities₹32.37₹3.58₹1.90₹2.02
Equity Capital₹248.38₹201.38₹149.15₹103.32
Total Equity & Liabilities₹301.31₹221.11₹166.33₹122.50
* All values are in INR Crore
Qty
Bid
2
428.35
8
428.25
129
428.15
2
428.1
1
428
Ask
Qty
428.95
249
429
200
429.15
1
429.2
9
429.3
45
Bid Total: 142
Ask Total: 504
Buy orders: 22%
Sell orders: 78%
Bearish
1
Neutral
6
Bullish
1
Neutral
by SEBI experts
Expert Pick
EXPPICK
Stop-loss
Entry price
Target
Indicator
Value
Verdict
RSI (14)
63.18
Neutral
ATR (14)
18.91
Neutral
STOCH(9,6)
62.62
Neutral
STOCH RSI (14)
72.88
Neutral
ADX(9)
53.99
Bearish
UO(9)
52.94
Neutral
ROC(12)
17.59
Bullish
WillR(14)
-27.76
Neutral
Period
Simple value
Exponential vaue
5D
415.69
414.09
10D
406.61
405.35
20D
382.85
391.89
50D
376.11
379.25
100D
372.96
371.28
Volume trend — traded volume by day
3 Sep11L
2 Sep17L
1 Sep7L
31 Aug6L
28 Aug2L
27 Aug4L
Average8L
Compare against other stocks
GUJARAT THEMIS BIOSYN LTD Share Price
GUJARAT THEMIS BIOSYN LTD
Pharmaceuticals
Add Stock
Add Another

GUJARAT THEMIS BIOSYN LTD Share Price FAQs